Trans-Oral Robotic Surgery (TORS) and Postoperative Hemorrhage: An Analysis of Risk Factors
Journal of Personalized Medicine · 16.05.2025 · 15 (5) · 201
DOI: 10.3390/jpm15050201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 16.05.2025. Verfasst von Andrea Migliorelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: ENT & Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, 44100 Ferrara, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Postoperative hemorrhage is the most common complication after Trans-Oral Robotic Surgery (TORS) described in the literature. The aim of this study is to assess the presence of any risk factors that may impact postoperative bleeding.
Methods
This was a retrospective study based on the analysis of patient data. Patients undergoing TORS procedures at the ENT Unit of Forlì Hospital from 2008 to 2022 for OSA (obstructive sleep apnea) or oncological disease and with a minimum follow-up of 30 days were included. The comorbidities analyzed were perioperative anticoagulant/antiplatelet therapy and clinicopathological features concerning the pathology. Total bleeding and severe bleeding (which required management in the operating room) were included.
Results
A total of 414 patients (106 oncological TORS and 308 OSA TORS patients) were included. Post-TORS bleeding occurred in 47 cases (11.3%) and severe bleeding in 18 cases (4.3%). The pathology (oncology vs. OSA) treated with TORS did not represent a risk factor (p = 0.466). Antiplatelet intake represented an important risk factor (p = 0.002). Postoperative hemorrhage for oncological TORS occurred in 11.3% patients; of these, 6.6% had severe bleeding. Artery ligation during neck dissection prevented the risk of severe bleeding (p < 0.001). In TORS for OSA, postoperative hemorrhage was found in 11.4% cases, of which 3.6% were major bleeding. Neither the degree of OSA nor the association with other concurrent procedures were risk factors for postoperative bleeding in this study.
Conclusions
Patients taking perioperative antiplatelet therapy have an almost 5-fold increased risk of developing postoperative bleeding. The pathology (oncology vs. OSA) does not influence the risk of bleeding. Prophylactic arterial ligation during neck dissection significantly decreases the risk of severe bleeding.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ENT & Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, 44100 Ferrara, Italy.
- Otolaryngology Unit, Department of Neurosciences (DNS), University of Padova, 35128 Padua, Italy.
- Gruppo Otorinolaringoiatrico della Romagna, GVM Care & Research, 48018 Faenza, Italy.
- ENT Department, Ospedale Morgagni Pierantoni, AUSL Romagna, 47121 Forlì, Italy.
ORCID-Profile: Andrea Migliorelli, Alberto Caranti, Andrea Ciorba
Zitieren
APA
Migliorelli, A., Biancoli, E., Manuelli, M., Caranti, A., Ciorba, A., Bianchini, C., Meccariello, G., & Vicini, C. (2025). Trans-Oral Robotic Surgery (TORS) and Postoperative Hemorrhage: An Analysis of Risk Factors. Journal of Personalized Medicine, 15(5), 201. https://doi.org/10.3390/jpm15050201
Vancouver
Migliorelli A, Biancoli E, Manuelli M, Caranti A, Ciorba A, Bianchini C, et al. Trans-Oral Robotic Surgery (TORS) and Postoperative Hemorrhage: An Analysis of Risk Factors. Journal of Personalized Medicine. 2025;15(5):201. doi:10.3390/jpm15050201
BibTeX
@article{Migliorelli2025,
author = {Migliorelli, Andrea and Biancoli, Elia and Manuelli, Marianna and Caranti, Alberto and Ciorba, Andrea and Bianchini, Chiara and Meccariello, Giuseppe and Vicini, Claudio},
title = {Trans-Oral Robotic Surgery (TORS) and Postoperative Hemorrhage: An Analysis of Risk Factors},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {5},
pages = {201},
doi = {10.3390/jpm15050201}
}
EUVIMED